Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Update

Aethlon Medical, Inc. (NASDAQ:AEMD) was the recipient of a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 351,100 shares, an increase of 22.7% from the October 31st total of 286,200 shares. Based on an average daily volume of 668,200 shares, the short-interest ratio is currently 0.5 days.

Analyst Upgrades and Downgrades

AEMD has been the subject of several research reports. StockNews.com started coverage on shares of Aethlon Medical in a research report on Monday. They issued a “sell” rating for the company. HC Wainwright reissued a “buy” rating and issued a $7.00 price objective on shares of Aethlon Medical in a research note on Friday, November 15th.

Aethlon Medical Trading Up 3.4 %

Shares of Aethlon Medical stock opened at $0.41 on Monday. Aethlon Medical has a 12 month low of $0.24 and a 12 month high of $2.35. The stock’s fifty day moving average price is $0.40 and its 200-day moving average price is $0.42. The firm has a market cap of $5.75 million, a P/E ratio of -0.15 and a beta of 1.74.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.